Cargando…
Fulminate anaerobic bacteremia after chemotherapy for metastatic breast cancer despite the prophylactic use of GCSF
Chemotherapy-induced neutropenia often occurs in our routine work and presents an obstacle for adequate (dose and continuance) treatment, which may affect patients’ outcome. Granulocyte colony-stimulating factors (GCSFs) effectively prevent myelosuppression and thus improve the standard treatment. T...
Autores principales: | Petrova, Mila, Mihaylova, Zhasmina, Fakirova, Albena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658216/ https://www.ncbi.nlm.nih.gov/pubmed/23754885 |
Ejemplares similares
-
Sorafenib in metastatic MTC – a case report and minireview of the literature
por: Petrova, Mila, et al.
Publicado: (2010) -
Granulocyte colony-stimulating factor (GCSF) fused with Fc Domain produced from E. coli is less effective than Polyethylene Glycol-conjugated GCSF
por: Do, Bich Hang, et al.
Publicado: (2017) -
Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
por: Aapro, M., et al.
Publicado: (2016) -
Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha
por: Talebkhan, Yeganeh, et al.
Publicado: (2016) -
Fulminant Pseudomembranous Colitis Leading to Clostridium Paraputrificum Bacteremia
por: Haider, Asim, et al.
Publicado: (2021)